Applied DNA Sciences (FRA:UDJ) Operating Cash Flow per Share : €-14.09 (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Applied DNA Sciences Operating Cash Flow per Share?

Applied DNA Sciences's operating cash flow per share for the three months ended in Mar. 2024 was €-3.39. Applied DNA Sciences's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was €-14.09.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 44.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 45.60% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 32.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Applied DNA Sciences's Operating Cash Flow per Share or its related term are showing as below:

FRA:UDJ' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -8.6 Med: 20.75 Max: 56.9
Current: 44.9

During the past 13 years, Applied DNA Sciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 56.90% per year. The lowest was -8.60% per year. And the median was 20.75% per year.

FRA:UDJ's 3-Year OCF Growth Rate is ranked better than
89.83% of 177 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.4 vs FRA:UDJ: 44.90

Applied DNA Sciences Operating Cash Flow per Share Historical Data

The historical data trend for Applied DNA Sciences's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences Operating Cash Flow per Share Chart

Applied DNA Sciences Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-135.46

-48.27

-32.89

-20.24

-8.91

Applied DNA Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.31	-1.96	-3.70	-5.04	-3.39

Competitive Comparison of Applied DNA Sciences's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, Applied DNA Sciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Applied DNA Sciences's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Applied DNA Sciences's Price-to-Operating-Cash-Flow falls into.

Applied DNA Sciences Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Applied DNA Sciences's Operating Cash Flow per Share for the fiscal year that ended in Sep. 2023 is calculated as

Operating Cash Flow per Share (A: Sep. 2023 )	=	Cash Flow from Operations (A: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (A: Sep. 2023 )
	=	-5.826	/	0.654
	=	-8.91

Applied DNA Sciences's Operating Cash Flow per Share for the quarter that ended in Sep. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-2.953	/	0.871
	=	-3.39

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-14.09

Applied DNA Sciences Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Applied DNA Sciences (FRA:UDJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (FRA:UDJ) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

APDN:USA UDJP:Germany

Address

50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790

Website

https://www.adnas.com

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Applied DNA Sciences (FRA:UDJ) Headlines

No Headlines